½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1591408

ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Noninvasive Ventilation Masks Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 176 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºñħ½ÀÀû ȯ±â(NIV) ¸¶½ºÅ© ½ÃÀå ±Ô¸ð´Â 2023³â 20¾ï 5,000¸¸ ´Þ·¯¿¡¼­ 2031³â 32¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀº 2023³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 5.9%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COPD ȯÀÚÀÇ °æ¿ì °¨¿°À̳ª ±â°èÀû Æó ¼Õ»ó°ú °°Àº ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ä§½ÀÀû ȯ±â ¹æ¹ýÀ» ÇÇÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ºñħ½ÀÀû ȯ±â ¸¶½ºÅ©´Â »ð°ü ¾øÀ̵µ È£ÈíÀ» µµ¿ÍÁֱ⠶§¹®¿¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

NIV¿ë Àç»ç¿ë °¡´ÉÇÑ ¸¶½ºÅ©´Â ȯÀÚÀÇ ÄÚ¿Í ÀÔÀ» µ¤°í Áö¼ÓÀû ±âµµ ¾ç¾Ð(CPAP) ¶Ç´Â 2´Ü°è ¾ç¾Ð(BPAP) ÀåÄ¡¿Í ¿¬°áµÇ´Â À¯¿¬ÇÏ°í À±°ûÀÌ ÀâÈù ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ºñħ½ÀÀû ¾ç¾Ð ȯ±â(NPPV)¸¦ À§ÇØ ÁÖº¯ °ø±â ¶Ç´Â ÀÇ·á¿ë »ê¼Ò(O2)¿Í °í¾Ð °ø±âÀÇ Á¶ÇÕÀ» È£Èí±â¿¡ °ø±ÞÇÏ¿© ºñħ½ÀÀû ¾ç¾Ð ȯ±â(NPPV)¸¦ À§ÇØ Çʸ³½º(Philips)ÀÇ PerformaTrak Àç»ç¿ë °¡´ÉÇÑ NIV ¸¶½ºÅ© ¶Ç´Â MSF InternationalÀÇ NIV, ºñÅëdz½Ä, ¿ÏÀü NIV ÆäÀ̽º ¸¶½ºÅ©¿Í ¿¬°áµË´Ï´Ù. nonvented, complete-NIV Face Mask µî ´Ù¾çÇÑ Á¦Ç°ÀÌ NIV Ä¡·á Áß Àç»ç¿ë °¡´ÉÇÑ NIV ¸¶½ºÅ©·Î ½ÃÆǵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àç»ç¿ë °¡´ÉÇÑ NIV ¸¶½ºÅ©´Â ÀÇ·á ±â°üÀÌ ¼Ò¸ðÇ° ºñ¿ëÀ» Àý°¨ÇÏ°í ȯÀÚ¿¡°Ô ºñħ½ÀÀûÀÌ°í Æí¾ÈÇÑ È¯±â¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¶ÇÇÑ, ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå¿¡¼­ È°µ¿ÇÏ´Â ¿¡¾î¸®Äûµå ÇコÄɾîÀÇ ÀÚȸ»ç ¿¡¾î¸®Äûµå ¸ÞµðÄà ½Ã½ºÅÛÁî´Â 2023³â 5¿ù ALNEST N1 »çÀÏ·±Æ® ¸¶½ºÅ©¸¦ Ãâ½ÃÇÏ¿´½À´Ï´Ù. ÀÌ Á¦Ç°Àº Quiet Flow Leak¿Í ÅëÇյǾî ÃÖÀûÀÇ ¼ÒÀ½ ¼öÁØ°ú ºÎµå·¯¿î È£Èí È®»êÀ» º¸ÀåÇÕ´Ï´Ù. ÀÌ È¸»ç°¡ »õ·Î Ãâ½Ã ÇÑ ALNEST N1 »çÀÏ·±Æ®¿Í ALNEST N1Àº º¸Á¤ µÈ È£±â ¿À¸®Çǽº°¡ÀÖ´Â Àç»ç¿ë °¡´ÉÇÑ ºñ°­ ¸¶½ºÅ©ÀÔ´Ï´Ù. ÀÌ NIV ¸¶½ºÅ©´Â CPAP ¹× BiPAP ¿ä¹ý°ú °°Àº NPPV¸¦ ó¹æ¹ÞÀº ȯÀÚ(üÁß 30kg ÀÌ»ó)°¡ ÁýÀ̳ª º´¿ø¿¡¼­ »ç¿ëÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. Á¶¿ëÇÑ È帧 ´©Ãâ, Á¶¿ëÇÑ È帧 ȯ±â Æ÷Æ®, Çõ½ÅÀûÀÎ Çìµå±â¾î µî ÷´Ü ±â¼úÀÌ Àû¿ëµÈ Á¦Ç°ÀÇ Ãâ½Ã·Î NIV Ä¡·á¿ë Àç»ç¿ë °¡´ÉÇÑ NIV ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñħ½ÀÀû ȯ±âÀÇ »ç¿ëÀÌ Å©°Ô Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, ÀçÅà ȯ°æ¿¡¼­ ±Þ¼º ¹× ¸¸¼º È£ÈíºÎÀü °ü¸®¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀçÅà ¿ä¾ç ȯ°æ¿¡¼­ÀÇ NIV Ä¡·á´Â ¸¸¼º ¾ÈÁ¤±â °úÈ£Èí ȯÀÚÀÇ »ýÁ¸À²°ú »îÀÇ ÁúÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, COPD·Î ÀÎÇÑ ±Þ¼º È£ÈíºÎÀüÀ¸·ÎºÎÅÍ È¸º¹µÈ ȯÀڴ ȣÈí¼º »êÁõÀÌ »ç¶óÁø ÈÄ ÃÖ¼Ò 2-4ÁÖ ÈÄ¿¡ Æò°¡ÇØ¾ß ÇÕ´Ï´Ù. µû¶ó¼­ Áý¿¡¼­ NIV¸¦ ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¸¼º °íÈ£ÈíºÎÀüÀÌ ¾ÈÁ¤µÈ COPD ȯÀÚµµ ÀçÅà NIVÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡À¸·Î ÀÎÇØ ÀçÅà °£È£¿¡¼­ NIV ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.

°³ÀÎÈ­µÈ NIV ¸¶½ºÅ©ÀÇ Çʿ伺Àº ³Î¸® Àνĵǰí ÀÖÀ¸¸ç, ÀáÀçÀûÀÎ Àü·«Àº ÀçÅà ȯ°æ¿¡¼­ ȯÀÚ¿¡°Ô Àå±âÀûÀ¸·Î »ç¿ëÇÏ´Â °Í¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. 2024³â 3¿ù, ÀÓÆ丮¾ó Ä®¸®Áö ·±´ø(Imperial College London)°ú ¼ÎÇÊµå ¾î¸°ÀÌ º´¿ø(Sheffield Children's Hospital)ÀÇ ¿¬±¸ÁøÀº ¾î¸°À̸¦ À§ÇÑ ÀÚ¼±´ÜüÀÎ Action Medical Research¿Í ÀÚ¼± ÀÇ·á ¿¬±¸ ´ÜüÀÎ LifeArcÀÇ ÀÚ±ÝÀ» Áö¿ø¹Þ¾Æ ¼Ò¾Æ ¸ÂÃãÇü NIV ¸¶½ºÅ©¸¦ ¸¸µå´Â ¿ÏÀü ÀÚµ¿È­µÈ Á¢±Ù¹ýÀ» °³¹ßÇß½À´Ï´Ù. Action Medical Research¿Í ÀÚ¼± ÀÇ·á ¿¬±¸ ´ÜüÀÎ LifeArcÀÇ Áö¿øÀ» ¹Þ¾Æ ¾î¸°À̸¦ À§ÇÑ ¸ÂÃãÇü NIV ¸¶½ºÅ© Á¦ÀÛÀ» À§ÇÑ ¿ÏÀü ÀÚµ¿È­µÈ Á¢±Ù ¹æ½ÄÀ» °³¹ßÇß½À´Ï´Ù. ÀÌ ÇÁ·ÎÁ§Æ®´Â Photocentric ¹× Polymetrix¿Í °°Àº ȸ»ç¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ÁøÇàµË´Ï´Ù. ¿¬±¸ ±â°üÀÇ ÀÌ·¯ÇÑ ³ë·ÂÀº ½ÃÀå¿¡ ÀÖ´Â ±â¾÷µé¿¡°Ô »õ·Î¿î °í°´À» È®º¸ÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ °¡Á®´Ù ÁÙ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ ±â¹Ý ÀλçÀÌÆ®

ÃÖÁ¾»ç¿ëÀÚº°·Î ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, ȨÄɾî, ±âŸ·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº 2023³â ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2031³â µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² Áö³­ ¼ö½Ê ³â µ¿¾È ÀÇ·á ºñ¿ëÀÌ Áõ°¡Çß½À´Ï´Ù. º´¿ø ±â¼úÀÇ ¹ßÀü, ÀÇ·á º¸Çè Á¤Ã¥ °³Çõ, ´Ù¾çÇÑ Áö¿ªÀÇ °æÁ¦ ¼ºÀå, °³¼± µÈ »óȯ ½Ã½ºÅÛ, Á¦°øµÇ´Â ´Ù¾çÇÑ Á¦Ç° ¹× ¼­ºñ½º µîÀÌ º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÇ ºñ ħ½ÀÀû ÀΰøÈ£Èí±â ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ÀÔ´Ï´Ù. õ½Ä, COPD ¹× ±âŸ ¸¸¼º È£Èí±âÁúȯ°ú °°Àº Áúº´ÀÇ Áõ°¡·Î ÀÎÇÑ ÀÔ¿ø ȯÀÚ ¼öÀÇ Áõ°¡¿Í NIV ¼­ºñ½º¸¦ Á¦°øÇÏ´Â Harefield Hospital, SingHealth Group of hospitals ¹× Royal Gwent Hospital°ú °°Àº º´¿øÀÇ Á¸ÀçµµÀÌ ºÎ¹®ÀÇ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¿µ±¹ ´ºÆ÷Æ®¿¡ À§Ä¡ÇÑ ·Î¾â ?Æ® º´¿øÀº 2017³âºÎÅÍ NIV ¿ä¹ýÀÌ ÇÊ¿äÇÑ È¯ÀÚÀÇ ÃÖÀû °ü¸®¸¦ ÃËÁøÇϱâ À§ÇØ NIV ȸ¼ö ¼­ºñ½º(NRS)¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù.

À¯¿£ °æÁ¦»çȸ±¹, ¼¼°èº¸°Ç±â±¸, Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ, ½ÄÇ°ÀǾ౹, À¯·´Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ´Â ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ 1Â÷ ¹× 2Â÷ Á¤º¸ Áß ÇϳªÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ±âÃÊ ¼öÄ¡ ÀÛ¼º
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå »óȲ

  • PEST ºÐ¼®

Á¦5Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • È£Èí±âÁúȯ À¯º´·ü Áõ°¡
    • ÀçÅà ÇコÄɾî ÁöÇâ »ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºñħ½ÀÀû ȯ±â(NIV) ¸¶½ºÅ©¿¡ µû¸¥ ºÎÀÛ¿ë
  • ½ÃÀå ±âȸ
    • ºñħ½ÀÀû ȯ±â(NIV) ä¿ë Áõ°¡
  • ÇâÈÄ µ¿Çâ
    • ±â¼úÀû Áøº¸ »ó½Â
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦6Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ¸ÅÃâ, 2021-2031³â
  • ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ¿¹Ãø ºÐ¼®

Á¦7Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ºÐ¼® - Á¦Ç°º°

  • ºñħ½ÀÀû ȯ±â ÀÏȸ¿ë ¸¶½ºÅ©
  • ºñħ½ÀÀû ȯ±â Àç»ç¿ë °¡´É ¸¶½ºÅ©

Á¦8Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ºÐ¼® - ¿ëµµº°

  • ¼ö¸é¹«È£ÈíÁõ
  • ¸¸¼ºÆó¼â¼ºÆóÁúȯ
  • Æó·Å
  • ±âŸ

Á¦9Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • ÀçÅÃÀÇ·á
  • ±âŸ

Á¦10Àå ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå - Áö¿ªº° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
    • ±âŸ Áß³²¹Ì

Á¦11Àå ¾÷°è »óȲ

  • ºñħ½ÀÀû ȯ±â ¸¶½ºÅ© ½ÃÀå ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Hamilton Medical AG
  • ResMed Inc
  • Fisher & Paykel Healthcare Corp Ltd
  • Air Liquide Medical Systems
  • Dragerwerk AG & Co KGaA
  • Intersurgical Ltd
  • BMC Medical Co Ltd
  • DeVilbiss Healthcare LLC
  • Armstrong Medical Ltd
  • Koninklijke Philips NV
  • Besmed Health Business Corp
  • Sleepnet Corporation.
  • SunMed Group Holdings LLC(AirLife)
  • Dimar S.P.A.
  • Hangzhou Formed Medical Devices Co., Ltd
  • SURU INTERNATIONAL PVT. LTD.
  • Medline Industries LP

Á¦13Àå ºÎ·Ï

ksm 24.11.26

The noninvasive ventilation masks market size is projected to reach US$ 3.25 billion by 2031 from US$ 2.05 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023-2031.

Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation masks are preferred because they provide breathing support without requiring intubation.

A NIV reusable mask is a flexible and contoured device that covers a patient's nose and mouth and connects with a continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BPAP) machine. This device supplies ambient air or a combination of medical oxygen (O2) and air at elevated pressure to the respiratory system for non-invasive positive pressure ventilation (NPPV). Various products such as PerformaTrak Reusable NIV Mask manufactured by Philips and NIV, non-vented, complete- NIV Face Mask by MSF International are commercially available NIV masks that can be reused during NIV therapy. These reusable NIV masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients.

Additionally, Air Liquide Medical Systems, a subsidiary of Air Liquide Healthcare operating in the noninvasive ventilation masks market, launched its ALNEST N1 Silent mask in May 2023. This product is integrated with Quiet Flow leak to ensure an optimal noise level and gent diffusion of the exhaled air. The company's newly launched Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices. These NIV masks are designed for home or hospital use by patients (weighing more than 30 kg) who have been prescribed NPPV, such as CPAP or BiPAP therapy. The launch of products with advanced technology, such as Quiet Flow leak, Quiet Flow ventilation port, and innovative headgear, is expected to increase the demand for reusable NIV masks for NIV therapy.

The use of noninvasive ventilation has increased significantly and has become an integral tool in the management of acute and chronic respiratory failure in the home setting. NIV therapy in a homecare setting helps improve survival and quality of life for chronic stable hypercapnia. The patients recovering from acute respiratory failure associated with COPD are required to be evaluated for at least 2-4 weeks after resolution of respiratory acidosis. Thus, they can be provided with NIV at home. Also, stable COPD patients with chronic hypercapnic respiratory failure can benefit from home NIV. These aforementioned benefits drive the demand for NIV masks in home care settings.

The need for personalized NIV masks is widely recognized, and potential strategies are focused on the long-term use of these masks in patients in home settings. In March 2024, researchers from Imperial College London and Sheffield Children's Hospital received funding from children's charity Action Medical Research and LifeArc, a charitable medical research organization, to develop a fully automated approach to creating customized NIV masks for children. This project will be carried out in partnership with companies such as Photocentric and Polymetrix. Such initiatives by research organizations are likely to bring opportunities for market players to attract new customers.

End User-Based Insights

Based on end user, the noninvasive ventilation masks market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share in the noninvasive ventilation masks market in 2023 and is expected to register the highest CAGR in the market during 2023-2031. There has been an increase in medical costs over the last few decades with developments in healthcare technology. Development in hospital technologies, reforms in health insurance policies, economic growth of various regions, improved reimbursement programs, and various products and services provided are among the major reasons fueling the noninvasive ventilation masks market growth for the hospital and clinics segment. The growing number of hospitalizations due to increasing incidences of diseases such as asthma, COPD, and other chronic respiratory disorders, and the worldwide presence of hospitals such as Harefield Hospital, SingHealth Group of hospitals, and the Royal Gwent Hospital that provide NIV services also drive the market growth for the segment. The Royal Gwent Hospital, Newport, UK, has been providing NIV retrieval services (NRS) since 2017 with the aim of facilitating optimal management of patients requiring NIV therapy.

United Nation Department of Economic and Social Affairs, World Health Organization, Centers for Diseases Control and Prevention, Food and Drug Administration, and European Center for Disease Prevention and Control are among the primary and secondary sources referred to while preparing the noninvasive ventilation masks market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Noninvasive Ventilation Masks Market Landscape

  • 4.1 PEST Analysis

5. Noninvasive Ventilation Masks Market - Key Market Dynamics

  • 5.1 Noninvasive Ventilation Masks Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Respiratory Diseases
    • 5.2.2 Growing Inclination Toward Home Healthcare
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with NIV Masks
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Adoption of NIV Masks
  • 5.5 Future Trends
    • 5.5.1 Rising Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Noninvasive Ventilation Masks Market - Global Market Analysis

  • 6.1 Noninvasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
  • 6.2 Noninvasive Ventilation Masks Market Forecast Analysis

7. Noninvasive Ventilation Masks Market Analysis - by Product

  • 7.1 Noninvasive Ventilation Disposable Mask
    • 7.1.1 Overview
    • 7.1.2 Noninvasive Ventilation Disposable Mask: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Noninvasive Ventilation Reusable Mask
    • 7.2.1 Overview
    • 7.2.2 Noninvasive Ventilation Reusable Mask: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)

8. Noninvasive Ventilation Masks Market Analysis - by Application

  • 8.1 Sleep Apnea
    • 8.1.1 Overview
    • 8.1.2 Sleep Apnea: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Chronic Obstructive Pulmonary Disease
    • 8.2.1 Overview
    • 8.2.2 Chronic Obstructive Pulmonary Disease: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Pneumonia
    • 8.3.1 Overview
    • 8.3.2 Pneumonia: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)

9. Noninvasive Ventilation Masks Market Analysis - by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Hospitals and Clinics: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Home Care
    • 9.2.1 Overview
    • 9.2.2 Home Care: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)

10. Noninvasive Ventilation Masks Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Noninvasive Ventilation Masks Market Overview
    • 10.2.2 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Noninvasive Ventilation Masks Market Breakdown, by Product
      • 10.2.3.1 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Product
    • 10.2.4 North America: Noninvasive Ventilation Masks Market Breakdown, by Application
      • 10.2.4.1 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.2.5.1 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.2.1 United States: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.2.6.2.2 United States: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.2.6.2.3 United States: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.2.6.3 Canada: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.3.1 Canada: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.2.6.3.2 Canada: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.2.6.3.3 Canada: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.2.6.4 Mexico: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.4.1 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.2.6.4.2 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: Noninvasive Ventilation Masks Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe Noninvasive Ventilation Masks Market Overview
    • 10.3.2 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
      • 10.3.3.1 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Product
    • 10.3.4 Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
      • 10.3.4.1 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.5.1 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 United Kingdom: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.2.1 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.2.2 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.2.3 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.6.3 Germany: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.3.1 Germany: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.3.2 Germany: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.3.3 Germany: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.6.4 France: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.4.1 France: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.4.2 France: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.4.3 France: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.6.5 Italy: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.5.1 Italy: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.5.2 Italy: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.5.3 Italy: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.6.6 Spain: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.6.1 Spain: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.6.2 Spain: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.6.3 Spain: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.3.6.7.2 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Noninvasive Ventilation Masks Market Overview
    • 10.4.2 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Product
      • 10.4.3.1 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Product
    • 10.4.4 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.5.1 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by End User
    • 10.4.6 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 China: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.2.1 China: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.2.2 China: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.2.3 China: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.6.3 Japan: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.3.1 Japan: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.3.2 Japan: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.3.3 Japan: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.6.4 India: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.4.1 India: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.4.2 India: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.4.3 India: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.6.5 Australia: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.5.1 Australia: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.5.2 Australia: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.5.3 Australia: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.6.6 South Korea: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.6.1 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.6.2 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.6.3 South Korea: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.4.6.7 Rest of APAC: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.4.6.7.2 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Noninvasive Ventilation Masks Market Overview
    • 10.5.2 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
      • 10.5.3.1 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Product
    • 10.5.4 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 South Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.2.1 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.5.6.2.2 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.5.6.2.3 South Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.5.6.3 Saudi Arabia: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.3.1 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.5.6.3.2 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.5.6.3.3 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.5.6.4.2 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.5.6.5.2 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America Noninvasive Ventilation Masks Market Overview
    • 10.6.2 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
      • 10.6.3.1 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Product
    • 10.6.4 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
      • 10.6.4.1 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.6.5.1 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.2.1 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.6.6.2.2 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.6.6.3 Argentina: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.3.1 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.6.6.3.2 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: Noninvasive Ventilation Masks Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: Noninvasive Ventilation Masks Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
        • 10.6.6.4.2 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Noninvasive Ventilation Mask Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Hamilton Medical AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 ResMed Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Fisher & Paykel Healthcare Corp Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Air Liquide Medical Systems
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Dragerwerk AG & Co KGaA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Intersurgical Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 BMC Medical Co Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DeVilbiss Healthcare LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Armstrong Medical Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Koninklijke Philips NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Besmed Health Business Corp
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Sleepnet Corporation.
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 SunMed Group Holdings LLC ( AirLife)
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Dimar S.P.A.
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Hangzhou Formed Medical Devices Co., Ltd
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 SURU INTERNATIONAL PVT. LTD.
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Medline Industries LP
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 Glossary of Terms
  • 13.2 About The Insight Partners
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦